Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

21 Dec 2020

Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program

TORONTO, Dec....

By Microdose

Press Releases

18 Dec 2020

Havn Life Sciences Files Preliminary Prospectus in Connection with Bought Deal Equity Financing

NOT FOR DISTRIBUTION TO U....

By Microdose

Press Releases

17 Dec 2020

Havn Life Sciences provides update on retail strategy and product development

Havn Retail is on track for its Q1 2021 launch of its initial line of natural health supplements....

By Microdose

Press Releases

16 Dec 2020

PURE EXTRACTS TECHNOLOGIES CORP. ANNOUNCES SPECIAL WARRANT OFFERING

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

16 Dec 2020

MindMed Announces $50 Million Bought Deal Public Offering

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NEW YORKDec....

By Microdose

Press Releases

16 Dec 2020

Havn Life Sciences hits major milestone with research partner, Complex Biotech Discovery Ventures

Havn Research signs contract with CBDV, located at The University of British Columbia’s Vancouver campus, to begin Health Canada approved research to analyze psilocybin under Havn Life’s Section 56 exemption....

By Microdose

Press Releases

16 Dec 2020

Pure Extracts Commences Build-Out of Facility in Preparation for Mushroom Extraction and Dealer’s Licence

Vancouver, B....

By Microdose

Press Releases

15 Dec 2020

Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

15 Dec 2020

Havn Life Sciences announces $5 million Bought Deal Financing

NOT FOR DISTRIBUTION TO U....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result